International Validation of the Comet Assay and a Human Intervention Study.

2.50
Hdl Handle:
http://hdl.handle.net/10146/234471
Title:
International Validation of the Comet Assay and a Human Intervention Study.
Authors:
Ersson, Clara
Abstract:
The comet assay is an established, sensitive method extensively used in biomonitoring studies. The methods' advantages include; a) only a small cell sample is required, b) possibility to measure damage in practically any cell type, c) ability to measure heterogeneity in response within a cell population, d) relatively fast and economical procedure, and e) various applications of the method, which allow measurement of a range of different DNA lesions as well as DNA repair. Several guidelines for the comet assay have been published, but no standardised protocol exists as yet. There are considerable differences between the protocols used by different research groups, which negatively affect inter-laboratory comparisons of results. Several experts in the field have highlighted the need for multi-laboratory, international validation studies, to assess intra- and inter-laboratory reproducibility and to investigate sources of variability in the results. The papers in this thesis can be divided into two parts; one part that deals with international inter-laboratory validation studies and methodological aspects of the comet assay (paper I-III), and the other part covers a human intervention study with antioxidant capsules consisting of many different antioxidants in low doses for which the comet assay has been applied (paper IV-V). The inter-laboratory validation trials in papers I-II indicate that the participants can detect dose-responses of both DNA breaks and oxidatively damaged DNA in coded cells, but that there is a large inter-laboratory variation in the reported values. This variation can in part be explained by differences in comet assay protocols and in image analysis. The inter-laboratory variation was decreased, but not completely removed, by calibration with ionising radiation. In paper III we verified that several protocol steps significantly affected the outcome of the comet assay, including a) density of the agarose gel, b) extent of enzymatic incubation, c) duration of alkaline treatment, and d) time of electrophoresis, as well as the strength of the electric field applied. In a parallel placebo-controlled, double-blind intervention study, overweight middle-aged men were supplemented for six weeks with a multivitamin supplement consisting of a range of antioxidants in doses resembling those achieved by a healthy diet (paper IV-V). In spite of elevated levels of seven out of eight measured antioxidants in the blood, the intervention did not affect the level of oxidation of lipids or DNA. Many intervention studies with good design report similar null findings. It is preferred to consume antioxidants through a healthy diet, and dietary supplements are not recommended for cancer prevention.
Citation:
Ersson C.: International validation of the comet assay and a human intervention study. Thesis Karolinska Institutet 2011.
Publisher:
Karolinska Institutet, 2011
Issue Date:
2011
URI:
http://hdl.handle.net/10146/234471
Additional Links:
http://publications.ki.se/jspui/bitstream/10616/40622/1/Clara_Ersson_Thesis.pdf
Type:
Thesis
Language:
en
ISBN:
978-91-7457-453-1
Sponsors:
The author of this thesis is a member of ECNIS (Environmental Cancer Risk, Nutrition and Individual Susceptibility), a network of excellence operating within the European Union 6th Framework Program, Priority 5: "Food Quality and Safety" (Contract No 513943), and ECVAG (the European Comet assay Validation Group) which was created within the ECNIS network of excellence in order to validate the comet assay.
Appears in Collections:
Theses

Full metadata record

DC FieldValue Language
dc.contributor.authorErsson, Claraen_GB
dc.date.accessioned2012-07-19T08:19:24Z-
dc.date.available2012-07-19T08:19:24Z-
dc.date.issued2011-
dc.identifier.citationErsson C.: International validation of the comet assay and a human intervention study. Thesis Karolinska Institutet 2011.en_GB
dc.identifier.isbn978-91-7457-453-1-
dc.identifier.urihttp://hdl.handle.net/10146/234471-
dc.description.abstractThe comet assay is an established, sensitive method extensively used in biomonitoring studies. The methods' advantages include; a) only a small cell sample is required, b) possibility to measure damage in practically any cell type, c) ability to measure heterogeneity in response within a cell population, d) relatively fast and economical procedure, and e) various applications of the method, which allow measurement of a range of different DNA lesions as well as DNA repair. Several guidelines for the comet assay have been published, but no standardised protocol exists as yet. There are considerable differences between the protocols used by different research groups, which negatively affect inter-laboratory comparisons of results. Several experts in the field have highlighted the need for multi-laboratory, international validation studies, to assess intra- and inter-laboratory reproducibility and to investigate sources of variability in the results. The papers in this thesis can be divided into two parts; one part that deals with international inter-laboratory validation studies and methodological aspects of the comet assay (paper I-III), and the other part covers a human intervention study with antioxidant capsules consisting of many different antioxidants in low doses for which the comet assay has been applied (paper IV-V). The inter-laboratory validation trials in papers I-II indicate that the participants can detect dose-responses of both DNA breaks and oxidatively damaged DNA in coded cells, but that there is a large inter-laboratory variation in the reported values. This variation can in part be explained by differences in comet assay protocols and in image analysis. The inter-laboratory variation was decreased, but not completely removed, by calibration with ionising radiation. In paper III we verified that several protocol steps significantly affected the outcome of the comet assay, including a) density of the agarose gel, b) extent of enzymatic incubation, c) duration of alkaline treatment, and d) time of electrophoresis, as well as the strength of the electric field applied. In a parallel placebo-controlled, double-blind intervention study, overweight middle-aged men were supplemented for six weeks with a multivitamin supplement consisting of a range of antioxidants in doses resembling those achieved by a healthy diet (paper IV-V). In spite of elevated levels of seven out of eight measured antioxidants in the blood, the intervention did not affect the level of oxidation of lipids or DNA. Many intervention studies with good design report similar null findings. It is preferred to consume antioxidants through a healthy diet, and dietary supplements are not recommended for cancer prevention.en_GB
dc.description.sponsorshipThe author of this thesis is a member of ECNIS (Environmental Cancer Risk, Nutrition and Individual Susceptibility), a network of excellence operating within the European Union 6th Framework Program, Priority 5: "Food Quality and Safety" (Contract No 513943), and ECVAG (the European Comet assay Validation Group) which was created within the ECNIS network of excellence in order to validate the comet assay.en_GB
dc.language.isoenen
dc.publisherKarolinska Institutet, 2011en_GB
dc.relation.urlhttp://publications.ki.se/jspui/bitstream/10616/40622/1/Clara_Ersson_Thesis.pdfen
dc.subjectBiomonitoringen_GB
dc.subjectDNA damageen_GB
dc.subjectDNA repairen_GB
dc.subjectComet assayen_GB
dc.subjectHumanen_GB
dc.subjectAntioxidantsen_GB
dc.subjectIntervention studyen_GB
dc.subjectInter-laboratory validationen_GB
dc.titleInternational Validation of the Comet Assay and a Human Intervention Study.en
dc.typeThesisen
All Items in ECNIS-NIOM are protected by copyright, with all rights reserved, unless otherwise indicated.